MICROSOMAL DRUG-METABOLISM IN CYSTIC-FIBROSIS

被引:0
|
作者
SALH, B
WEBB, K
BRAGANZA, JM
SANDLE, LR
机构
[1] MANCHESTER ROYAL INFIRM,MANCHESTER M13 9WL,LANCS,ENGLAND
[2] MONSALL HOSP,MANCHESTER,ENGLAND
[3] PARK HOSP,MANCHESTER,ENGLAND
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:P235 / P236
页数:2
相关论文
共 50 条
  • [21] METABOLISM OF CIPROFLOXACIN IN PATIENTS WITH CYSTIC-FIBROSIS
    MATTIE, H
    VANGULPEN, C
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1131 - S1132
  • [22] DRUG CLEARANCE IN PATIENTS WITH CYSTIC-FIBROSIS
    WEINBERGER, MM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 106 - 106
  • [23] Drug bests cystic-fibrosis mutation
    Ledford, Heidi
    NATURE, 2012, 482 (7384) : 145 - 145
  • [24] Drug bests cystic-fibrosis mutation
    Heidi Ledford
    Nature, 2012, 482 : 145 - 145
  • [25] HEPATIC DRUG CLEARANCE IN CYSTIC-FIBROSIS
    KEARNS, GL
    GALLORY, GB
    CROM, WR
    EVANS, WE
    PHARMACOTHERAPY, 1988, 8 (02): : 127 - 127
  • [26] HEPATIC DRUG CLEARANCE IN CYSTIC-FIBROSIS
    KEARNS, GL
    MALLORY, GB
    CROM, WR
    EVANS, WE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 130 - 130
  • [27] BIOENGINEERED CYSTIC-FIBROSIS DRUG APPROVED
    THAYER, A
    CHEMICAL & ENGINEERING NEWS, 1994, 72 (02) : 5 - 5
  • [28] SUMMARY OF DRUG NEEDS IN CYSTIC-FIBROSIS
    BOUCHER, RC
    BEALL, RJ
    PHARMACEUTICAL RESEARCH, 1989, 6 (06) : 525 - 526
  • [29] MICROSOMAL DYSFUNCTION INDUCED BY CHOLESTASIS - DRUG-METABOLISM IN MAN
    CARULLI, N
    SALVIOLI, GF
    MANENTI, F
    RINALDI, G
    GALLO, M
    DIGESTION, 1972, 6 (4-5) : 256 - &
  • [30] KETOCONAZOLE INHIBITS HEPATIC-MICROSOMAL DRUG-METABOLISM
    MOSCA, P
    NOVELLI, G
    ORLANDI, F
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1984, 16 (04): : 323 - 323